Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120758580A reveals enzymatic route for (S)-chiral amines. High ee value, mild conditions. Reliable supplier for pharma intermediates.
Novel acylation of ketimines route for high-purity pyrazole derivatives offering cost reduction and supply chain reliability for agrochemical intermediates.
Patent CN85106474A reveals a novel route for herbicide intermediates using accessible raw materials. Discover cost-effective synthesis and supply chain advantages for thiophene derivatives.
Patent CN116286700B reveals enhanced imine reductase mutants for nicotine synthesis offering superior yield and supply chain reliability for global pharmaceutical manufacturers.
Patent CN121159538A reveals a novel folic acid synthesis route optimizing imine intermediates for higher purity and cost reduction in vitamin manufacturing supply chains.
Novel iridium catalyst enables anti-Markovnikov hydroamination. Enhances yield and stability for pharmaceutical intermediate manufacturing supply chains.
Patent CN110627691A reveals a mild catalytic route for high-purity perfluoroalkyl sulfonylation reagents. Achieve significant cost reduction and supply chain reliability.
Patent CN120574796A enables high-purity (S)-nornicotine production. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN116024284A reveals mutant imine reductase for S-nicotine. Achieve >99% ee and high conversion. Reliable pharmaceutical intermediate supplier for cost reduction.
Novel one-pot method for Roflumilast reduces hazardous reagents. Enhances supply chain reliability and cost reduction in API intermediate manufacturing.
Patent CN119823959B reveals novel imine reductase mutants for high-purity chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101402646B discloses high-intensity blue fluorescent cadmium complexes for OLEDs, offering simplified synthesis and superior monochromatic performance for display manufacturing.
Patent CN113402434A reveals a green electrochemical route for NH-sulfoximines. Discover cost-effective, scalable manufacturing for high-purity pharmaceutical intermediates.
Patent CN115948360B reveals high-efficiency biocatalytic route for neurodegenerative drug intermediates with superior stereoselectivity and scalable production potential.
Novel Rh-catalyzed route to fused macrocyclic sulfoximines. High yield, room temp process reduces manufacturing costs and ensures supply continuity for pharma intermediates.
Advanced synthesis of fungicidal pyrido[4,3-d]pyrimidine derivatives. Optimized routes for cost-effective agrochemical intermediate manufacturing and scalable supply chain solutions.
Patent CN114539327B reveals stable P,N,N-ligand for propargyl conversion. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108276433B discloses a novel Mg-Mg catalyzed ester hydroboration method. High yield, room temperature operation enables cost reduction in pharmaceutical intermediate manufacturing.
Novel nickel imine complex catalyzes cyclohexylacetylene hydroamination. High yield, mild conditions, cost-effective manufacturing solution.
Novel catalytic dehydration process ensures high purity aziridine. Reduces costs and enhances supply chain reliability for global pharmaceutical manufacturers.